In addition, pharmaceutically targeting the αv integrin/TGF-β axis in combination with allogeneic NK cells in a glioblastoma stem cell (GSC)-engrafted mouse model promotes the antitumor function of NK cells and tumor growth (120). This evidence concerns the gene TGFB1 and neoplasm.